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Quality Improvement Study to Evaluate the Effects of Implementation of a Rapid Identification 
Diagnostic Test on Multidrug-Resistant Bloodstream Infections at a Large Academic Institution
Bloodstream infections (BSI) are severe infections with a high 
associated patient mortality. Studies show that gram negative 
bacteria contribute to approximately 25% of BSI and have 
become increasingly resistant to antibiotic therapy and exhibit 
extended-spectrum beta-lactamases (ESBL) and carbapenem-
resistance genes. Vancomycin-resistant Enterococcus (VRE) 
BSI also appear to becoming more prevalent. The introduction 
of a rapid nucleic acid identification test (NAT) for BSI that 
identifies the bacteria and its resistance markers promises 
results with a turnaround time of 2 hours. This allows for prompt 
modification of the patient’s antibiotic therapy. This test was 
introduced to the Lehigh Valley Health Network Cedar Crest 
and Muhlenberg campuses on April 13th, 2015.
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Table 1: Results of MDR Organism Identification and Appropriate 
Escalation of Antibiotics before and after Introduction of NAT
• Time to identify the MDR organism from collection of the 
blood sample was significantly lower using the NAT
• Average time to appropriate antibiotics from blood culture 
collection date showed a trend toward improvement
• Time to appropriate antibiotics after identification of a MDR 
organism did not improve significantly in the post-intervention 
cohort
– Providers may not be familiar with NAT and more education may be 
necessary
– More patients in the pre-intervention cohort had an ID consult or an 
antecedent culture revealing a MDR organism
• Of the MDR organisms identified 
in this study, ESBL seemed the 
most prevalent
• 30-day patient mortality did not 
significantly change after NAT 
implementation
– Larger studies with more data is needed
to address this topic
• NAT data was received from the Health Network 
Laboratories
• Results were analyzed for appropriate antibiotic 
escalation from time for the following:
– Antibiotic initiation
– Blood culture result
– Blood culture collection
• Basic statistical measures were implemented to assist in 
interpreting results
The study shows that the NAT for BSI provides rapid results 
compared to traditional identification methods. This study in 
particular was limited by a small sample size (n=69) with a 
disproportionate number of participants per cohort. 
Therefore, support from larger studies is required to confirm 
results.






This retrospective study sought to analyze the effect of the 
NAT compared to traditional multidrug-resistance (MDR) 
identification methods in the following areas:
• Time to result
• Time to appropriate antibiotics
• Impact on 30-day mortality rates
69 patients qualified for 
retrospective study
Pre-NAT Intervention
(April 13th, 2014 – April 12th, 2015)
n=24
Post-NAT Intervention













Mean time to identification of MDR 
organism (±SD), hours
68.4 (10) 27.6 (18) <0.001
Mean time to appropriate antibiotics from 
antibiotic initiation (±SD), hours
76.3 (81) 92.9 (130) 0.529
Mean time to appropriate antibiotics from 
MDR organism identification (±SD), 
hours
-26.7 (33) 6.8 (29) <0.001
Mean time to appropriate antibiotics from 
blood culture collection (±SD), hours
41.8 (30) 34.3 (32) 0.364
Mean time to appropriate antibiotics from 
MDR identification with Infectious 
Diseases (ID) consultation (±SD), hours


















































Figure 1: Time to Appropriate Antibiotic Escalation 
from Blood Culture Collection Period
**Excludes patients with death prior to availability of blood culture results
*Abbreviations: Extended-spectrum beta-lactamase 
(ESBL), Vancomycin-resistant Enterococcal (VRE), and 
Carbapenem-resistant Enterobacteriaceae (CRE)
